专利检索 ap:("Novartis Pharma AG" OR "NOVARTIS-PHARMA GMBH") AND inv:"BATT, David Bryant" 第 1 页

1.

发明公开
HETEROCYCLIC ORGANIC COMPOUNDS FOR THE TREATMENT OF IN PARTICULAR MELANOMA 审中-公开
标题翻译：杂环有机化合物，特别是对黑色素瘤的治疗

公开(公告)号：EP2001864A1

公开(公告)日：2008-12-17

申请号：EP07753076.4

申请日：2007-03-14

申请人： Novartis Pharma AG , NOVARTIS-PHARMA GMBH

发明人： BATT, David Bryant , BEERLI, René , BOLD, Guido , CARAVATTI, Giorgio , RAMSEY, Timothy Michael

IPC分类号： C07D401/04 , C07D401/14 , A61K31/506 , A61P35/00 , A61P25/00 , A61P29/00

CPC分类号： C07D401/04

摘要： The present invention relates to the discovery that certain compounds inhibit, regulate and/or modulate tyrosine and serine/threonine kinase and kinase-like proteins, such as RAF kinase, a serine/threonine kinase that functions in the MAP kinase signaling pathway, and is concerned with compositions which contain these compounds, and methods of using them to treat tyrosine and serine/threonine kinase and kinase-like dependent diseases, such as angiogenesis, cancer and cardiac hypertrophy. (Formula I).